tiprankstipranks
Trending News
More News >
Contineum Therapeutics, Inc. Class A (CTNM)
NASDAQ:CTNM
US Market

Compare Contineum Therapeutics, Inc. Class A (CTNM) vs. Competitors

Compare
210 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Contineum Therapeutics, Inc. Class A
$11.84
$429.59M
-5.25
-8.64%
6 Buy
1 Hold
0 Sell
Strong Buy
Tvardi Therapeutics
$4.51
$43.44M
-0.46
-66.29%
2 Buy
3 Hold
0 Sell
Moderate Buy
Capricor Therapeutics
$24.04
$1.35B
-13.37
78.47%
8 Buy
0 Hold
0 Sell
Strong Buy
Alpha Tau Medical Ltd
$5.84
$639.48M
-14.73
99.48%
3 Buy
0 Hold
0 Sell
Strong Buy
Immuneering
$4.43
$286.04M
-2.60
144.21%
4 Buy
0 Hold
0 Sell
Strong Buy
enGene Holdings
$9.22
$609.56M
-4.02
24.09%
7 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CTNM
Contineum Therapeutics, Inc. Class A
11.84
-0.60
-4.82%
TVRD
Tvardi Therapeutics
4.51
-9.44
-67.67%
CAPR
Capricor Therapeutics
24.04
10.34
75.47%
DRTS
Alpha Tau Medical Ltd
7.68
3.77
96.42%
IMRX
Immuneering
4.64
2.62
129.70%
ENGN
enGene Holdings
9.22
2.08
29.13%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts